Earnings call transcript: Demant Q2 2025 revenue miss leads to stock dip

Demant A/S reported Q2 2025 earnings with revenue of $5.63 billion, falling short of the $5.88 billion forecast, which prompted a 4.03% decline in its stock price during after-hours trading. The hearing aid company also lowered its full-year EBIT guidance to DKK 3.9-4.3 billion, attributing the revised outlook to macroeconomic uncertainty, market volatility, and increased competition, particularly within the Costco channel, resulting in 0% organic growth. Despite maintaining a robust 75.8% gross margin, investor concerns are evident, highlighting the challenging market dynamics even as the company emphasizes continued investment in AI-driven product innovation.

Analysis

Demant A/S reported challenging second-quarter 2025 results, characterized by a significant revenue miss and a downward revision of its full-year EBIT guidance, which prompted a 4.03% stock price decline in after-hours trading. The company posted revenue of 5.63 billion USD against a forecast of 5.88 billion USD, a 4.25% shortfall driven by stagnating 0% organic growth. Management attributes this weakness primarily to pervasive macroeconomic uncertainty, which is suppressing consumer demand and causing the global hearing aid market to grow at 1-3%, well below the historical 4-6% range. Compounding this market-wide issue are company-specific headwinds, including an unfavorable geographic sales mix that is depressing the average selling price (ASP) and a material, unexpected loss of market share in the critical Costco channel due to the addition of a new competitor. This channel shift alone accounts for approximately one-third of the DKK 200 million midpoint reduction in EBIT guidance. Despite these pressures, the company maintains a robust 75.8% gross margin, tight control over operating expenses, and is proceeding with strategic investments, including the acquisition of the Kin Group and planned AI-driven product launches in the second half.

Key Decisions for Investors

• Investors should closely monitor competitive dynamics within the Costco channel, as the unexpected addition of a new supplier has materially impacted sales and was a key driver for the EBIT guidance reduction.
• Given that management attributes the demand slowdown primarily to persistent macroeconomic uncertainty, positions should be weighed against the risk of a prolonged period of weak consumer sentiment impacting hearing aid sales.
• Look for potential catalysts in the second half of the year, particularly the market reception of planned AI-driven product launches and the successful integration of the Kin Group acquisition, which are key to offsetting near-term pressures.